| STK005635 | Clc1ccc(c(c1)Cl)N1C(=O)NC(=O)/C(=C\c2cccn2c2ccccc2)/C1=O | (5E)-1-(2,4-dichlorophenyl)-5-[(1-phenyl-1H-pyrrol-2-yl)methylidene]pyrimidine-2,4,6(1H,3H,5H)-trione | C21H13Cl2N3O3 | 426.26 g/mol |
| STK005636 | CCCCCC(=O)NC(=S)Nc1ccc2c(c1)nn(n2)c1ccc(cc1)CCCC | N-{[2-(4-butylphenyl)-2H-benzotriazol-5-yl]carbamothioyl}hexanamide | C23H29N5OS | 423.58 g/mol |
| STK005637 | CCOC(=O)C(C(=O)OCC)(NC(=O)C)CCC#N | diethyl (acetylamino)(2-cyanoethyl)propanedioate | C12H18N2O5 | 270.29 g/mol |
| STK005638 | CCCCOc1ccc(cc1)C(=O)Nc1nnc(s1)COc1cc(C)ccc1C(C)C | 4-butoxy-N-(5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,3,4-thiadiazol-2-yl)benzamide | C24H29N3O3S | 439.58 g/mol |
| STK005639 | N#C/C(=c/1\[nH]c2c([nH]1)cccc2)/C(=O)COc1cccc(c1C)C | 2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-4-(2,3-dimethylphenoxy)-3-oxobutanenitrile | C19H17N3O2 | 319.36 g/mol |
| STK005640 | COn1c(nc2c1CCc1c2non1)c1ccccc1 | 6-methoxy-7-phenyl-5,6-dihydro-4H-imidazo[4,5-e][2,1,3]benzoxadiazole | C14H12N4O2 | 268.28 g/mol |
| STK005641 | O=C(Nc1ccc(c(c1)C)Br)Cc1ccc(cc1)Cl | N-(4-bromo-3-methylphenyl)-2-(4-chlorophenyl)acetamide | C15H13BrClNO | 338.63 g/mol |
| STK005642 | O=C(N/N=C\1/c2ccccc2N(C1=O)CN1CCCCC1)CSc1nc2c(o1)cccc2 | 2-(1,3-benzoxazol-2-ylsulfanyl)-N'-[(3Z)-2-oxo-1-(piperidin-1-ylmethyl)-1,2-dihydro-3H-indol-3-ylidene]acetohydrazide | C23H23N5O3S | 449.53 g/mol |
| STK005643 | CCOc1cc(/C=C/2\C(=O)NN(C2=O)c2ccccc2)cc(c1OCCOc1ccc(c(c1)C)C)Br | (4E)-4-{3-bromo-4-[2-(3,4-dimethylphenoxy)ethoxy]-5-ethoxybenzylidene}-1-phenylpyrazolidine-3,5-dione | C28H27BrN2O5 | 551.44 g/mol |
| STK005644 | COc1ccc(cc1)NC(=O)CC(=O)c1ccc(cc1)[N+](=O)[O-] | N-(4-methoxyphenyl)-3-(4-nitrophenyl)-3-oxopropanamide | C16H14N2O5 | 314.30 g/mol |
| STK005645 | O=C(Nc1nccs1)/C=C/c1ccccc1 | (2E)-3-phenyl-N-(1,3-thiazol-2-yl)prop-2-enamide | C12H10N2OS | 230.29 g/mol |
| STK005646 | CCCCCCCCCOc1ccc(c(c1)O)c1ccc2c(n1)CCC(C2)CCCCCCC | 2-(6-heptyl-5,6,7,8-tetrahydroquinolin-2-yl)-5-(nonyloxy)phenol | C31H47NO2 | 465.72 g/mol |
